Puration Inc. (OTCPK: PURA), an extraction cannabis company, announced Thursday its financial earnings for the first quarter of 2020.
The report comes about three months after Puration made an offer to buy an undisclosed CBD pet product operation.
That acquisition came on the heels of an announcement that Puration and Kali-Extracts Inc. KALY are negotiating Puration’s intention to purchase the cannabis company.
The following month, both parties confirmed the planned acquisition is underway.
Dallas-based Puration which saw its revenue spike 173% year-over-year, reaching $805,000. Here's a breakdown of what the earnings report showed:
- Pura’s gross revenue was $241,790
- Annual revenue of $2.7 million
- That's up by 121% compared to the $1.2 million the company generated in 2018
- A net profit of more than $200,000
The producer of EVERx CBD Infused Sports Drink also reported ordinary general expenses of roughly $130,000 per quarter.
Puration also said it plans to publish a narrative update on Friday, May 22, further revealing details regarding the first-quarter financial report and its 100% annual revenue growth outlook for 2020.
Furthermore, it will provide information on its cannabis cultivation operations related to Nouveau Life Pharmaceuticals, Inc. (OTC: NOUV).
In addition, Kali reported it had submitted a novel patent application based on its CBD formulation for relieving symptoms of COPD and related respiratory conditions.
Courtesy photo.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Cannabis is evolving – don’t get left behind!
Curious about what’s next for the industry and how to leverage California’s unique market?
Join top executives, policymakers, and investors at the Benzinga Cannabis Market Spotlight in Anaheim, CA, at the House of Blues on November 12. Dive deep into the latest strategies, investment trends, and brand insights that are shaping the future of cannabis!
Get your tickets now to secure your spot and avoid last-minute price hikes.